OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)

R. Aymon, D. Mongin, S. A. Bergstra, D. Choquette, C. Codreanu, R. L. Cordtz, D. C. Diederik, L. Dreyer, O. Elkayam, D. Huschek, K. Hyrich, F. Iannone, N. Inanc, L. Kearsley-Fleet, T. K Kvien, B. Leeb, G. Lukina, D. Nordström, F. Onen, K. PavelkaM. Pombo-Suarez, S. Aarrestad Provan, A. M. Rodrigues, Z. Rotar, A. Strangfeld, P. Verschueren, J. Zavada, D. Courvoisier, A. Finckh, K. Lauper

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberOP0219
JournalAnnals of the Rheumatic Diseases
Volume82
Issue numberSuppl. 1
Pages (from-to)143-145
Number of pages3
ISSN0003-4967
DOIs
Publication statusPublished - Jun 2023
EventEULAR 2023 European Congress of Rheumatology - Milan, Italy
Duration: 31 May 20233 Jun 2023
https://congress.eular.org/index.cfm

Conference

ConferenceEULAR 2023 European Congress of Rheumatology
Country/TerritoryItaly
CityMilan
Period31/05/202303/06/2023
Internet address

Bibliographical note

Abstract No. OP0219

Cite this